LBA Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$90K Hold
1,381
0.05% 154
2016
Q4
$86K Hold
1,381
0.05% 154
2016
Q3
$87K Hold
1,381
0.05% 162
2016
Q2
$85K Buy
1,381
+125
+10% +$7.62K 0.05% 164
2016
Q1
$72K Hold
1,256
0.04% 174
2015
Q4
$74K Buy
1,256
+1,040
+481% +$59.9K 0.04% 186
2015
Q3
$12K Sell
216
-900
-81% -$58.6K 0.01% 253
2015
Q2
$75K Hold
1,116
0.05% 150
2015
Q1
$65K Hold
1,116
0.04% 156
2014
Q4
$73K Sell
1,116
-186
-14% -$11.7K 0.05% 155
2014
Q3
$75K Buy
1,302
+302
+30% +$16.8K 0.05% 153
2014
Q2
$56K Hold
1,000
0.05% 157
2014
Q1
$51K Hold
1,000
0.04% 155
2013
Q4
$53K Buy
+1,000
New +$49.1K 0.04% 153

Other funds holding ABBV

LBA Wealth Management's ABBV Position: Q1 2017 in Review

LBA Wealth Management held its AbbVie (ABBV) position steady in Q1 2017 at 1,381 shares worth $90K. The position accounts for 0.05% of the portfolio, ranked #154.

LBA Wealth Management first reported a position in ABBV in Q4 2013 and has held it in 14 quarters since. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • LBA Wealth Management held 1,381 shares of AbbVie worth $90K as of Q1 2017.
  • LBA Wealth Management left its AbbVie share count unchanged in Q1 2017.
  • AbbVie made up 0.05% of LBA Wealth Management's portfolio in Q1 2017, its #154 holding.
  • LBA Wealth Management first reported a position in AbbVie in Q4 2013 and has held it in 14 quarters since.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on LBA Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.